134 related articles for article (PubMed ID: 33477422)
21. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.
Maeda K; Doi S; Nakashima A; Nagai T; Irifuku T; Ueno T; Masaki T
PLoS One; 2017; 12(3):e0173706. PubMed ID: 28278257
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.
Matsubara H; Tsuchiya H; Watanabe K; Takeuchi A; Tomita K
Clin Orthop Relat Res; 2008 Dec; 466(12):2962-72. PubMed ID: 18813894
[TBL] [Abstract][Full Text] [Related]
24. Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.
Nishino T; Ashida R; Obata Y; Furusu A; Abe K; Miyazaki M; Koji T; Kohno S
Ren Fail; 2012; 34(6):760-6. PubMed ID: 22506622
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis.
Watanabe M; Ebina M; Orson FM; Nakamura A; Kubota K; Koinuma D; Akiyama K; Maemondo M; Okouchi S; Tahara M; Matsumoto K; Nakamura T; Nukiwa T
Mol Ther; 2005 Jul; 12(1):58-67. PubMed ID: 15963921
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficiency and toxicity of sonoporation with branched polyethylenimine-mediated gene transfection in various cultured cell lines.
Yoon CS; Jung HS; Kim TK; Kwon MJ; Kim MK; Lee M; Koh KS; Rhee BD; Park JH
J Drug Target; 2008 Dec; 16(10):773-9. PubMed ID: 19005939
[TBL] [Abstract][Full Text] [Related]
27. Possible role of hepatocyte growth factor in regeneration of human peritoneal mesothelial cells.
Naiki Y; Matsuo K; Matsuoka T; Maeda Y
Int J Artif Organs; 2005 Feb; 28(2):141-9. PubMed ID: 15770602
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of early avascular necrosis of femoral head by core decompression and transplantation of human hepatic growth factor gene-modified osteoblasts: experiment with rabbits].
Dang HS; Pei FX; Shen B; Yang J; Zhou ZK; Lu F; Peng WZ
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):484-9. PubMed ID: 18642792
[TBL] [Abstract][Full Text] [Related]
29. Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumors.
Francone TD; Landmann RG; Chen CT; Sun MY; Kuntz EJ; Zeng Z; Dematteo RP; Paty PB; Weiser MR
Mol Cancer Ther; 2007 Apr; 6(4):1460-6. PubMed ID: 17431125
[TBL] [Abstract][Full Text] [Related]
30. Beneficial effects of enalapril on chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Ke CY; Lin NT; Hsu BG
Chin J Physiol; 2011 Aug; 54(4):225-34. PubMed ID: 22129820
[TBL] [Abstract][Full Text] [Related]
31. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
32. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat.
Guo H; Leung JC; Chan LY; Tsang AW; Lam MF; Lan HY; Lai KN
Gene Ther; 2007 Dec; 14(24):1712-20. PubMed ID: 17960163
[TBL] [Abstract][Full Text] [Related]
33. Aliskiren ameliorates chlorhexidine digluconate-induced peritoneal fibrosis in rats.
Ke CY; Lee CC; Lee CJ; Subeq YM; Lee RP; Hsu BG
Eur J Clin Invest; 2010 Apr; 40(4):301-9. PubMed ID: 20486991
[TBL] [Abstract][Full Text] [Related]
34. Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.
Liu KH; Zhou N; Zou Y; Yang YY; OuYang SX; Liang YM
Med Sci Monit; 2019 Dec; 25():9346-9356. PubMed ID: 31812978
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
36. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
37. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats.
Cruzado JM; Lloberas N; Torras J; Riera M; Fillat C; Herrero-Fresneda I; Aran JM; Alperovich G; Vidal A; Grinyó JM
Diabetes; 2004 Apr; 53(4):1119-27. PubMed ID: 15047630
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats.
Ro Y; Hamada C; Inaba M; Io H; Kaneko K; Tomino Y
Nephrol Dial Transplant; 2007 Oct; 22(10):2838-48. PubMed ID: 17545675
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.
Iwasaki T; Imado T; Kitano S; Sano H
Arthritis Res Ther; 2006; 8(6):R161. PubMed ID: 17049072
[TBL] [Abstract][Full Text] [Related]
40. Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice.
Yoh K; Ojima M; Takahashi S
Exp Anim; 2015; 64(4):353-62. PubMed ID: 26156402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
